四氯化碳诱导的肝纤维化小鼠肝组织VEGF表达变化*

doi:10.3969/j.issn.1672-5069.2016.01.020

Abstract

Fu Zhihui, Li Sanqiang, Ding Kangxi, et al. Expression of vascular endothelial growth factor in liver tissues in mice with carbon tetrachloride-induced liver fibrosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 81-82.

References

[1] 陈珊,金伟,闵平,等. 血管内皮生长因子家族及其受体与肿瘤血管生成研究进展. 生命科学,2004,16（1）：19-23.
[2] Gressner AM,Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Cell Mol Med,2006,10（3）:76-99.
[3] 张海燕,温韬,卢静,等. 四氯化碳诱导大鼠慢性肝损伤模型方法的探讨. 实用肝脏病杂志,2009,12（3）：161-224.
[4] 许建明,徐叔云,张运芳,等. 四氯化碳诱导小鼠肝纤维化模型的建立. 中国药理学通报,2000,16（3）：339-341.
[5] Reeves HL,Friedman SL. Activation of hepatic stellate cells—a key issue in liver fibrosis. Front Biosci,2002,7（1）:808-826.
[6] Shackel NA,McGuinness PH,Abbott CA,et al. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut,2001,49（4）:565-576.
[7] 郭艳萍,杨广英,王建君,等. 转化生长因子-β1及VEGF在肝纤维化中的表达. 中华实用诊断与治疗杂志,2008,22（10）：724-725.
[8] 陈从新,刘波,马勇,等. 拉米夫定和干扰素α及苦参素碱防治乙型肝炎肝衰竭生存者的肝纤维化进展. 中华肝脏病杂志,2009,17（7）：505-508.
[9] 王全楚. 肝衰竭后肝纤维化阻断研究的初步探讨及体会. 实用肝脏病杂志,2012,15（1）：67-69.
[10] 曹仕煜,陈永锋. 血管内皮生长因子及其受体与肿瘤的关系. 医学综述,2008,14：3412-3415.
[11] Lee C,Sintich SM,Mathews EP,et al. Transforming growth factor-betain benign and malignant prosetate.Prosetate,2001,39（4）:285-290.
[12] 马红,谢明星. 超声造影在肝纤维化及肝硬化诊断中的研究进展. 实用诊断与治疗杂志,2007,21（7）：530-532.
[13] Mochida S,Ishikawa K,Inao M,et al. Increased expressions of vascular endothelial growth factor and its receptors,flt-1 and KDR/flk-1,in regenerating rat liver. Biochem Biophys Res Commun, 1996,226（1）:176-179.
[14] Kraizer Y,Mawasi N,Seagal J,et al. Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun,2001,287（10）:209-215.
[15] 程琳,拥忠,邓靖宇,等. VEGF在肝脏疾病中的研究进展. 中国民康医学杂志,2005,17：386-388.
[16] 刘卫英,肖琳,张泽高,等. 乙型肝炎和肝硬化患者血清血管紧张素系统的变化及其与肝纤维化的关系. 实用肝脏病杂志,2014,17（4）：352-355.

Expression of vascular endothelial growth factor in liver tissues in mice with carbon tetrachloride-induced liver fibrosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xu Fei, Li Weirong.. Protective effects of astragaloside in rats with CCL₄-induced liver injuries [J]. Journal of Practical Hepatology, 2019, 22(6): 808-811.
[2]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[3]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[4]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[5]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[6]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[7]	Zhou Liyun, Li Xiaotian, Li Li. 1,25（OH）₂D₃ inhibits hepatic fibrosis by regulating miR-146a levels in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 333-336.
[8]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[9]	Yusup Tursun, Zhao Yanxia.. Establishment of low-dose diethylnitrosamine-induced liver fibrosis model in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 33-36.
[10]	Guo Xiaoxia, Guo Beiting, Kong Xianglu.. Effects of splenectomy on hepatic fibrosis in mice with poly I:C-induced primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 837-841.
[11]	Huang Chunming, Yang Zhan, Nie Yuqiang, et al.. Prediction of liver fibrosis by gamma-glutamyl-transpeptidase-to-platelet ratio in patients with chronic hepatitis B viral infection with normal serum transaminase levels [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 859-862.
[12]	Sui Ling, Du Jikun, Zheng Jingbin.. Protective effect of curcumin on CCl₄-induced acute liver injury in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 709-712.
[13]	Zheng Zhenchuan, Xu Xihai.. Pathological and clinical features and factors affecting significant liver fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 713-716.
[14]	Wang Quanhui, Zhang Yuanhao, Yuan Shouxin, et al.. Effect of 1aparoscopic hepatectomy on peripheral blood T lymphocyte subsets and serum cytokines in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 753-756.
[15]	Ren Tao, Pan Wen, Xu Li, et al. Clinical features of liver cirrhosis in Tibetan minority [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 352-355.